BACK TO CONTENTS   |    PDF   |    PREVIOUS   |    NEXT

Title

A two-step drug repositioning method based on a protein-protein interaction network of genes shared by two diseases and the similarity of drugs

 

Authors

Yutaka Fukuoka*, Daiki Takei & Hisamichi Ogawa

 

Affiliation

Department of Electrical Engineering, Faculty of Engineering, Kogakuin University, 1-24-2 Nishi-Shinjuku, Shinjuku, Tokyo 163-8677, Japan.

 

Email

fukuoka@cc.kogakuin.ac.jp; *Corresponding author

 

Article Type

Hypothesis

 

Date

Received January 07, 2013; Accepted January 08, 2013; Published January 18, 2013

 

Abstract

The present study proposed a two-step drug repositioning method based on a protein-protein interaction (PPI) network of two diseases and the similarity of the drugs prescribed for one of the two. In the proposed method, first, lists of disease related genes were obtained from a meta-database called Genotator. Then genes shared by a pair of diseases were sought. At the first step of the method, if a drug having its target(s) in the PPI network, the drug was deemed a repositioning candidate. Because targets of many drugs are still unknown, the similarities between the prescribed drugs for a specific disease were used to infer repositioning candidates at the second step. As a first attempt, we applied the proposed method to four different types of diseases: hypertension, diabetes mellitus, Crohn disease, and autism. Some repositioning candidates were found both at the first and second steps.

 

Keywords

Drug repositioning, Disease related genes, Drug target, Drug interaction, Substructure, Side effect, Protein-Protein interaction network.

 

Citation

Fukuoka et al Bioinformation 9(2): 089-093 (2013)

 

Edited by

P Kangueane

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.